Alexander & Baldwin (NYSE:ALEX) reported quarterly earnings of $0.09 per share which missed the analyst consensus estimate of $0.12 by 25 percent. This is a 250 percent increase over losses of $(0.06) per share from the same period last year.
Crinetics’ CRN04777 Shows Dose-Dependent Suppression of Fasting Insulin
Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) announced topline results from the multiple ascending dose (MAD) cohorts of healthy volunteers in the Phase 1…